United States of America ex rel. ADVENTIST HEALTH SYSTEM OF WEST v. ABBVIE INC.
The Ninth Circuit reversed the dismissal of a qui tam action alleging drug manufacturers violated the False Claims Act by inflating prices under the Section 340B Program. The court held that while the Supreme Court barred direct private suits to enforce Section 340B, the False Claims Act provides an independent cause of action for fraud against the government that is not precluded by that limitation.